2024
Advances in the development of new vaccines for tuberculosis and Brazil’s role in the effort forward the end TB strategy
Junqueira-Kipnis A, de Cerqueira Leite L, Croda J, Chimara E, Carvalho A, Arcêncio R. Advances in the development of new vaccines for tuberculosis and Brazil’s role in the effort forward the end TB strategy. Memórias Do Instituto Oswaldo Cruz 2024, 119: e240093. PMID: 39383403, PMCID: PMC11452070, DOI: 10.1590/0074-02760240093.Peer-Reviewed Original Research
2023
Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil
de Oliveira L, de Rezende I, Navarini V, Marchioro S, Torres A, Croda J, Croda M, Gonçalves C, Xavier J, de Castro E, Lima M, Iani F, Adelino T, Aburjaile F, Demarchi L, Taira D, Zardin M, Fonseca V, Giovanetti M, Andrews J, Alcantara L, Simionatto S. Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil. Frontiers In Public Health 2023, 11: 1195779. PMID: 37965526, PMCID: PMC10641392, DOI: 10.3389/fpubh.2023.1195779.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 lineagesIntroduction eventsCharacterization of SARS-CoV-2Nanopore sequencing platformSARS-CoV-2 positive samplesMultiple SARS-CoV-2 variantsMultiple introduction eventsPhylogenetic reconstructionPhylogenetic dataGenome sequenceSequencing platformsGenomic characterizationSARS-CoV-2Genomic surveillanceSARS-CoV-2 variantsLineagesMato GrossoMortality rateViral dynamicsIndigenous populationCo-circulationPrevalence of malesMidwestern BrazilPositive samplesIndigenous mobilizationPan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API)
Barbosa A, Chebabo A, Starling C, Pérez C, Cunha C, de Luna D, Nunes E, Zambrano G, Ferreira J, Croda J, Falavigna M, Gomes-da-Silva M, Thormann M, Cimerman S, Parahiba S, Tanni S, Bernardo W, Rodriguez-Morales A. Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API). Annals Of Clinical Microbiology And Antimicrobials 2023, 22: 67. PMID: 37550690, PMCID: PMC10408214, DOI: 10.1186/s12941-023-00623-w.Peer-Reviewed Original ResearchConceptsUse of hydroxychloroquineInfectious diseasesCOVID-19Treatment of outpatientsSARS-CoV-2/COVIDSevere COVID-19Evidence-based guidelinesPan American AssociationGuideline development processLack of benefitEvidence-based medicineAdverse eventsMechanical ventilationClinical manifestationsTherapeutic optionsPharmacological treatmentCOVID-19 episodeInpatient settingAmerican guidelinesGRADE systemSystematic reviewStrong recommendationsProphylaxisOutpatientsDiseaseUnveiling the Impact of the Omicron Variant: Insights from Genomic Surveillance in Mato Grosso do Sul, Midwest Brazil
de Mello Almeida Maziero L, Giovanetti M, Fonseca V, Zardin M, de Castro Lichs G, de Rezende Romera G, Tsuha D, Frias D, Escandolhero V, Demarchi L, Castilho L, Barbosa K, Tebet D, Xavier J, Fritsch H, Lima M, de Oliveira C, Santos E, Kashima S, do Carmo Said R, Rosewell A, Croda J, Alcantara L, Gonçalves C. Unveiling the Impact of the Omicron Variant: Insights from Genomic Surveillance in Mato Grosso do Sul, Midwest Brazil. Viruses 2023, 15: 1604. PMID: 37515290, PMCID: PMC10386548, DOI: 10.3390/v15071604.Peer-Reviewed Original ResearchConceptsGenomic surveillanceWhole-genome sequencingMultiple introduction eventsGenome sequencePublic health interventionsGenomic dataGenomic monitoringIntroduction eventsPublic health responseGenomic landscapeDispersal dynamicsPhylodynamic analysesPublic health laboratoriesHealth interventionsMato GrossoHealth responseTransmissible variantsSignificant burdenCentral Public Health LaboratoryOmicron variantVariantsHealth laboratoriesSequenceMidwest region of BrazilViral strains
2022
Are we near the end of the pandemic?
Maciel E, Oliveira W, Siqueira P, Croda J. Are we near the end of the pandemic? Revista Da Sociedade Brasileira De Medicina Tropical 2022, 55: e0233-2022. PMID: 35613223, PMCID: PMC9131776, DOI: 10.1590/0037-8682-0233-2022.Peer-Reviewed Original ResearchCoronavirus disease COVID-19 pandemic and the Declaration of Public Health Emergency in Brazil: administrative and epidemiological aspects
de Oliveira W, de Góes Cavalcanti L, Croda J. Coronavirus disease COVID-19 pandemic and the Declaration of Public Health Emergency in Brazil: administrative and epidemiological aspects. Revista Da Sociedade Brasileira De Medicina Tropical 2022, 55: e0227-2022. PMID: 35613222, PMCID: PMC9131777, DOI: 10.1590/0037-8682-0227-2022.Peer-Reviewed Original Research
2020
Serial interval distribution of SARS-CoV-2 infection in Brazil
Prete C, Buss L, Dighe A, Porto V, da Silva Candido D, Ghilardi F, Pybus O, de Oliveira W, Croda J, Sabino E, Faria N, Donnelly C, Nascimento V. Serial interval distribution of SARS-CoV-2 infection in Brazil. Journal Of Travel Medicine 2020, 28: taaa115. PMID: 32710618, PMCID: PMC7454808, DOI: 10.1093/jtm/taaa115.Peer-Reviewed Original ResearchEffect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Borba M, Val F, Sampaio V, Alexandre M, Melo G, Brito M, Mourão M, Brito-Sousa J, Baía-da-Silva D, Guerra M, Hajjar L, Pinto R, Balieiro A, Pacheco A, Santos J, Naveca F, Xavier M, Siqueira A, Schwarzbold A, Croda J, Nogueira M, Romero G, Bassat Q, Fontes C, Albuquerque B, Daniel-Ribeiro C, Monteiro W, Lacerda M. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. JAMA Network Open 2020, 3: e208857. PMID: 32330277, DOI: 10.1001/jamanetworkopen.2020.8857.Peer-Reviewed Original ResearchConceptsHigh dosage groupSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionAcute respiratory syndrome coronavirus 2 infectionLow dosage groupSyndrome coronavirus 2 infectionCoronavirus 2 infectionChloroquine diphosphateDay 13COVID-19Phase IIb clinical trialNonsevere COVID-19Secondary end pointsSevere COVID-19High-dose groupSpecific antiviral therapyTertiary care facilityIIb clinical trialCoronavirus disease 2019More heart diseaseParticipants' clinical statusAdjunctive therapyAdult patientsIll patientsPrimary outcomeAntiviral therapyCOVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases
Croda J, de Oliveira W, Frutuoso R, Mandetta L, Baia-da-Silva D, Brito-Sousa J, Monteiro W, Lacerda M. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases. Revista Da Sociedade Brasileira De Medicina Tropical 2020, 53: e20200167. PMID: 32320998, PMCID: PMC7182282, DOI: 10.1590/0037-8682-0167-2020.Peer-Reviewed Original ResearchConceptsCoronavirus disease 2019New coronavirus disease 2019Public health emergencyWorld Health OrganizationCOVID-19 casesUnified Health SystemDisease 2019First COVID-19 caseSevere casesHealth systemHealth OrganizationHealth emergencyCOVID-19First caseFuture studiesInternational concernEarly preparationImportation and early local transmission of COVID-19 in Brazil, 2020
de Jesus J, Sacchi C, da Silva Candido D, Claro I, Sales F, Manuli E, da Silva D, de Paiva T, Pinho M, de Oliveira Santos K, Hill S, Aguiar R, Romero F, dos Santos F, Gonçalves C, do Carmo Timenetsky M, Quick J, Croda J, de Oliveira W, Rambaut A, Pybus O, Loman N, Sabino E, Faria N. Importation and early local transmission of COVID-19 in Brazil, 2020. Revista Do Instituto De Medicina Tropical De São Paulo 2020, 62: e30. PMID: 32401959, PMCID: PMC7232955, DOI: 10.1590/s1678-9946202062030.Peer-Reviewed Original Research